echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Metformin, amoxilin and other 55 drug price reduction unseeded varieties price linkage does not drop the network

    Metformin, amoxilin and other 55 drug price reduction unseeded varieties price linkage does not drop the network

    • Last Update: 2021-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In November, most provinces and cities across the country will use the third batch of national varieties after the price reduction.
    metformin, ibuprofen, amoselin... At the end of this month, the country implemented the results of the third batch of national mining in August this year, the third batch of national mining in Shanghai, a total of 55 drugs were selected, the average price reduction of 53%, the highest decline of 95%.
    in addition to high blood pressure, diabetes, antibiotics and other commonly used drugs, the first-line sugar-lowering drug metformin, in the country has more than 5 billion yuan of large-scale market, in the third batch of national tender opening day competition is extremely fierce.
    In addition to metformin, omeprazole, ibuprofen, dopamine, finasteride, amoxicillin and more than 10 varieties reported a dime price, vitamin B6, katopuri, chlorine and nitrogen equal offer of a few cents.
    , provinces and cities began to implement the third batch of national harvest results.
    incomplete statistics, there are currently 28 provinces and cities clear landing implementation date, is expected to be able to use most parts of the country at the end of this month after the third batch of national harvest varieties.
    From the current implementation of the third batch of national harvest results, hydrochloric acid metformin tablets specifications of 0.5g x 60 tablets, the original hanging network price of 65.8 yuan per box, after the price reduction of each box is expected to reach 3.4 yuan; 51 yuan, the price after the price reduction of 16.48 yuan, a drop of 89%; Menglust sodium chewing tablets from the original 81.14 yuan / box, reduced to 2.98 yuan / box, a drop of up to 96.3%; Prior to the original research drug companies in the third batch of national mining in a large number of abandonment of the bid caused concern, data show that a number of original research drugs almost monopolized the market, 38 original research drugs accounted for more than half of their respective areas of market share.
    The original research drug enterprises to abandon the market, on the one hand may be in the maintenance of the global price system of drugs, on the other hand, the original research drug by virtue of the accumulation of word-of-mouth, brand effect over the years, but also in the market outside the collection, the off-site market channels become the place to win and fail to select products.
    and because of the withdrawal of the original drug research enterprises, generic pharmaceutical companies can have more market space in the hospital, the situation of the monopoly of the original research drug will be gone forever.
    Not selected product price linkage, "removal tide" to attack for the selected products, especially the original market share is not high products, through this volume of procurement can better expand market share, and for the unseeded products, some places can also start to implement price linkage in the near future, and the enterprise quotation did not reach the established range will be cancelled hanging network, whether through consistent evaluation of the product in the price reduction "treatment" also has a great difference.
    e.g. Heilongjiang Province requires the third batch of non-selected pharmaceutical production enterprises to fill in the lowest prices in other provinces of the country (excluding the third batch of nationally selected prices); The minimum purchase price of a drug trading platform as its purchase price, the implementation of the province-wide price linkage, with the selected drugs with the generic name, the same dosage form, different specifications of non-selected drugs, according to the voluntary principle of the implementation of the price linkage; Sichuan Province: non-selected drugs and joint procurement of the formation of a gradient of price reduction results to maintain price linkage.
    the differential price rule, all non-selected drugs are not higher than the Shanghai maximum price drug price reduction results.
    non-selected drugs with different refined dosage forms, specifications and packaging of the selected drugs shall be adjusted according to the price difference of the selected drugs, and the prices of other non-selected drugs that have not passed the consistent evaluation shall not be higher than the price of the selected drugs.
    Qinghai Province: the state centralized procurement did not choose Qinghai Province as the supply area of the selected drugs, to no higher than the selected price directly hung on the network; The unseeded drugs are directly listed at no higher than the selected drug price in Qinghai Province as the supply area, and the untransced drugs not evaluated under the generic name are listed directly on the net at a lower price than the selected drugs selected in Qinghai Province as the supply area, and not higher than the unestactioned drugs and the lowest purchase price in the country.
    the same time, some places also require that the unselevered review has been full of three products, disqualifying the network.
    For example, Sichuan Province mentioned that "belongs to the third batch of generic drugs, the same variety of drugs through the consistent evaluation of the production enterprises reached more than 3, the failure to pass the consistent evaluation of the online trading function temporarily closed, pending the adoption of the consistency evaluation of the relevant enterprises can be re-declared and opened."
    ", Qinghai Province pointed out that the same varieties of drugs through the conformity evaluation reached more than 3 (including 3), no longer failed to pass the conformity evaluation of generic drugs on the network ... At present, the national collection of drugs has been carried out to the third batch, before the industry forecast the fourth batch at the end of the year or early next year, in the volume of procurement mechanism, the selected varieties, unseeded varieties, as well as failed to select and failed to pass the consistent evaluation of the market share will be reshuffled, not selected without evaluation of the varieties face the survival crisis.
    the first two batches of collection and implementation, Sanofi, Beijing Jialin, Xinlitai, etc. have been exposed to the reduction of sales staff.
    the current cold winter has come, a large number of pharmaceutical representatives due to changes in the sales environment will face elimination and transformation.
    with the collection, consistent evaluation, medical insurance and other in-depth promotion, since this year, many pharmaceutical companies began to transform, layoffs, the wave of enterprise departures also reached a small peak.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.